|
*Please note: This is the first of several exciting announcements the CFIDS Association has to share this week -- watch your inbox!*
The Office of Research on Women's Health of the National Institutes of Health has just announced funding for seven new studies of chronic fatigue syndrome (CFS). According to today's press release, "The proposed studies will help researchers understand how the diverse symptoms in CFS are related to the interactions between the immune and neurological systems—an important step towards developing effective treatments for a disabling condition."
The awards are made as a result of the special Request for Applications (RFA) issued in July 2005 to stimulate interest in CFS resesarch. The CFIDS Association of America led advocacy efforts to secure the RFA as a means of sending a signal to the research community that opportunities exist in CFS research. 29 proposals were received in response to this announcement and 7 grants were awarded. The Office of Women's Health and four other institutes will provide the nearly $4 million in funding to support the studies.
A list of the grants is provided below; the NIH press release describes the wide-ranging studies. Four of the seven investigators are new to the CFS research field, while the other three bring years of experience to their work. Recruiting new investigators to the study of CFS is one of the Association's key research goals.
Thank NIH Director Dr. Elias Zerhouni and Office of Research on Women's Health Director Dr. Vivian Pinn for issuing the RFA and committing funds to these studies. Just follow the prompt to Take Action! and then click on the box marked GO!
New NIH Grantees:
University of
Miami, Dr. Michael Antoni, “Cognitive Behavioral Stress Management for Chronic Fatigue Syndrome;”
Georgetown
University, Dr. James Baraniuk, “Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome;
Vanderbilt
University, Dr. Italo Biaggioni, “Autonomic Nervous System in Chronic Fatigue Syndrome;
University of
Miami, Dr. Mary Ann Fletcher, “Neuropeptide Y and dipeptidyl-peptidase IV (CD26) in chronic fatigue syndrome;”
University of
Utah, Dr. Kathleen Light, “Stress and Neuroimmune Dysergulation in Chronic Fatigue Patients;”
Sun Health Research Institute, Dr. Dianne Lorton, “Human Spinal Cord Glial Cytokines and Chronic Pain;” and,
Tufts
University, Dr. Theoharis Theoharides, “Mast cells, antidepressants and chronic fatigue syndrome.”
The ORWH has also posted a new fact sheet on CFS as part of the Science Series 2006. You can view it at http://orwh.od.nih.gov/cfs/Chronic_Fatigue_Science_Series_FINAL.pdf
|
